MedTrace Logo

Extended Follow-Up of the ISS T-003 Trial Volunteers (ISS T-003 EF-UP2020)

NCT05680948 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 179

Last updated 2026-03-27

No results posted yet for this study

Summary

A further extension of the follow-up of the volunteers of the ISS T-003 trial is being conducted in order to evaluate the persistence of vaccine immunogenicity as well as of the immunological and virological effects induced by the therapeutic immunization with Tat after about 10 years from vaccination.

Conditions

  • HIV Infections

Sponsors & Collaborators

  • Istituto Superiore di Sanità

    lead OTHER

Principal Investigators

  • Maphoshane MN Nchabeleng, MD · Sefako Makgatho Health Sciences University - Mecru Clinical Research Unit (MeCRU),

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-25
Primary Completion
2023-12-31
Completion
2024-06-30

Countries

  • South Africa

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05680948 on ClinicalTrials.gov